Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Payments of Stock Issuance Costs

2.2 / 5 stars · 23/52 Roast Me

Definium Therapeutics, Inc. Payments of Stock Issuance Costs

Definium Therapeutics, Inc. (DFTX) reported Payments of Stock Issuance Costs of $46.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06

  • Definium Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $15.95M.
  • Definium Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • Definium Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • Definium Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • Definium Therapeutics, Inc. payments of stock issuance costs for fiscal 2025 was $15.95M, a 0.89% decline from fiscal 2024.
  • Definium Therapeutics, Inc. payments of stock issuance costs for fiscal 2024 was $16.09M.
  • Definium Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $0.00.
  • Definium Therapeutics, Inc. payments of stock issuance costs for fiscal 2020 was $395.00K.
Period endPayments of Stock Issuance Costs 3 monthPayments of Stock Issuance Costs 6 monthPayments of Stock Issuance Costs 9 monthPayments of Stock Issuance Costs 9 month as first filedPayments of Stock Issuance Costs 12 monthPayments of Stock Issuance Costs 12 month as first filed
2026-06-30$46.42M
10-Q · filed 2026-08-06
2025-12-31$15.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$15.95M
derived: sum of 2 quarters · filed 2026-02-26
$15.95M
derived: sum of 3 quarters · filed 2026-08-06
$15.95M
10-K · filed 2026-02-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2026-08-06
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$0.00
10-Q · filed 2026-08-06
$0.00
derived: sum of 3 quarters · filed 2026-08-06
$5.28M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$5.28M
derived: sum of 3 quarters · filed 2026-02-26
$7.37M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$5.28M
derived: sum of 2 quarters · filed 2026-02-26
$7.37M
derived: sum of 3 quarters · filed 2026-02-26
$16.09M
10-K · filed 2026-02-26
$11.06M
10-K · filed 2025-03-06
2024-09-30$5.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$7.37M
derived: sum of 2 quarters · filed 2025-11-06
$16.09M
10-Q · filed 2025-11-06
$11.06M
10-Q · filed 2024-11-07
$16.09M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$2.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$10.81M
10-Q · filed 2025-07-31
$10.81M
derived: sum of 3 quarters · filed 2025-07-31
2024-03-31$8.72M
10-Q · filed 2025-05-08
$8.72M
derived: sum of 2 quarters · filed 2025-05-08
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$0.00
10-K · filed 2025-03-06
2023-09-30$0.00
10-Q · filed 2024-11-07
2020-12-31$395.00K
10-K · filed 2022-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B